Efficient Drug Development
TNO works with public and private parties to create and implement innovative technologies that make the process of drug development – from laboratory to patient – more efficient. This will make it possible to cut development costs and to get drugs to patients sooner.
![](/publish/pages/2791/tno-steven-erpelinck-cp-500x500.jpg)
Our latest developments
13 resultaten, getoond 1 t/m 5
TNO launches Peregrion to boost market impact of its technology that accelerates medicine development
Ten years of development at TNO has yielded a track record and acceptance by regulators of the accelerated biomedical mass spectrometry (AMS) technology.
![](/publish/pages/10614/spin-off-peregrion-index-789x442.jpg)
![](/publish/pages/10614/spin-off-peregrion-index-789x442.jpg)
PPP uncovers new insights into MASLD development
![](/publish/pages/10385/index-pps-proliver-masld-v2-789x442.jpg)
![](/publish/pages/10385/index-pps-proliver-masld-v2-789x442.jpg)
Translational preclinical efficacy models
![](/publish/pages/10321/index-preclinical-efficacy-models-v2-789x442.jpg)
![](/publish/pages/10321/index-preclinical-efficacy-models-v2-789x442.jpg)
Time setters: reduce long waits for new medication with AMS
![](/publish/pages/9348/tijdmakers-ams-index4-789x442.jpg)
![](/publish/pages/9348/tijdmakers-ams-index4-789x442.jpg)
Ex vivo organ perfusion provides accurate drug development data
![](/publish/pages/8501/website-orgaanperfusie-index-789x442jpg.jpg)
![](/publish/pages/8501/website-orgaanperfusie-index-789x442jpg.jpg)